Tissue Regenix Group Plc (TRX) — Strategic Asset Allocation Index
Tissue Regenix Group Plc (TRX) has a Strategic Asset Allocation Index of 37.9% as of June 2023. Strategic assets (PP&E of GBX8.90 Million plus long-term investments of GBX-) total GBX8.90 Million, measured against net assets of GBX23.46 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See TRX net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Tissue Regenix Group Plc Strategic Asset Allocation Index (2008–2022)
This chart shows how Tissue Regenix Group Plc's Strategic Asset Allocation Index has evolved across 15 annual periods from 2008 to 2022. As of June 2023, the index stands at 37.9%, representing strategic assets of GBX8.90 Million against net assets of GBX23.46 Million GBX. For live market cap and overall valuation, see TRX market cap overview.
Annual Strategic Asset Allocation Index for Tissue Regenix Group Plc (2008–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Tissue Regenix Group Plc from 2008 to 2022, covering 15 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Tissue Regenix Group Plc for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 35.4% | GBX8.94 Million | GBX8.94 Million | GBX- | GBX25.27 Million | ▼ -1.5 pp |
| 2021 | 36.9% | GBX9.10 Million | GBX9.10 Million | GBX- | GBX24.65 Million | ▲ +16.4 pp |
| 2020 | 20.5% | GBX5.71 Million | GBX5.71 Million | GBX- | GBX27.85 Million | ▲ +10.9 pp |
| 2019 | 9.6% | GBX2.36 Million | GBX2.36 Million | GBX- | GBX24.59 Million | ▲ +0.9 pp |
| 2018 | 8.7% | GBX2.83 Million | GBX2.83 Million | GBX- | GBX32.57 Million | ▲ +1.1 pp |
| 2017 | 7.6% | GBX2.99 Million | GBX2.99 Million | GBX- | GBX39.52 Million | ▼ -1.8 pp |
| 2016 | 9.4% | GBX1.09 Million | GBX1.09 Million | GBX- | GBX11.54 Million | ▲ +6.4 pp |
| 2016 | 3.0% | GBX901.00K | GBX901.00K | GBX- | GBX30.25 Million | ▼ -0.8 pp |
| 2015 | 3.8% | GBX435.00K | GBX435.00K | GBX- | GBX11.58 Million | ▲ +2.2 pp |
| 2014 | 1.5% | GBX472.00K | GBX472.00K | GBX- | GBX31.30 Million | ▲ +0.9 pp |
| 2013 | 0.6% | GBX238.00K | GBX238.00K | GBX- | GBX38.64 Million | ▲ +0.3 pp |
| 2012 | 0.4% | GBX157.00K | GBX157.00K | GBX- | GBX43.78 Million | ▼ -1.6 pp |
| 2011 | 1.9% | GBX189.00K | GBX189.00K | GBX- | GBX9.84 Million | ▲ +1.9 pp |
| 2009 | 0.1% | GBX2.00K | GBX2.00K | GBX- | GBX3.63 Million | ▲ +0.0 pp |
| 2008 | 0.0% | GBX2.00K | GBX2.00K | GBX- | GBX9.68 Million | — |